Beaumont Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.03M Sell
8,037
-53
-0.7% -$6.2K 0.4% 41
2026
Q1
$973K Buy
8,090
+73
+0.9% +$8.43K 0.44% 38
2025
Q4
$844K Sell
8,017
-13
-0.2% -$1.22K 0.42% 39
2025
Q3
$674K Sell
8,030
-283
-3% -$23.3K 0.34% 44
2025
Q2
$658K Buy
8,313
+179
+2% +$14.2K 0.35% 43
2025
Q1
$730K Buy
+8,134
New +$759K 0.44% 40

Other funds holding MRK

Beaumont Asset Management's MRK Position: Q2 2026 in Review

Beaumont Asset Management reduced its Merck (MRK) stake by 0.66% in Q2 2026, selling an estimated $6.2K and leaving 8,037 shares worth $1.03M. The position accounts for 0.4% of the portfolio, ranked #41.

Beaumont Asset Management first reported a position in MRK in Q1 2025 and has held it in 6 quarters since. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Beaumont Asset Management held 8,037 shares of Merck worth $1.03M as of Q2 2026.
  • Beaumont Asset Management sold 53 Merck shares in Q2 2026, an estimated $6.2K.
  • Merck made up 0.4% of Beaumont Asset Management's portfolio in Q2 2026, its #41 holding.
  • Beaumont Asset Management first reported a position in Merck in Q1 2025 and has held it in 6 quarters since.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Beaumont Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.